| Date | Form | Description | Docs | XBRL | Pages |
| 01/29/13 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
|
244 |
| 01/28/13 | 8-K | Current report filing |
|
3 | |
| 12/07/12 | 3 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 12/04/12 | 8-K | Current report filing |
|
5 | |
| 12/04/12 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 12/04/12 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 12/04/12 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 11/15/12 | CT ORDER | Confidential treatment order |
|
1 | |
| 11/08/12 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
|
2 | |
| 11/08/12 | 8-K | Current report filing |
|
20 |
Latest News & Events
Anixa Biosciences Announces Dr. Jose Conejo-Garcia will Keynote the South Carolina Clinical & Translational Research Institute 2026 Retreat
Read More...Anixa Biosciences Reports Encouraging Patient Survival Observations in Ovarian Cancer CAR-T Trial; Achieves Regulatory Approval Enabling Major Dose Escalation
Read More...Anixa Biosciences Secures United States Adopted Names Council Approval of Non-Proprietary Name for its CAR-T Therapy, a Key Step Toward Future Commercialization
Read More...